Asia Pacific Pneumonia Vaccines Market By Vaccine Type (Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV)), By Product Type (Prevnar 13, Synflorix and Pneumovax23), By sector (Public sector and Private sector), By Distribution Channel (Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Pneumonia Vaccines Market, by Vaccine Type
1.4.2 Asia Pacific Pneumonia Vaccines Market, by Product Type
1.4.3 Asia Pacific Pneumonia Vaccines Market, by Sector
1.4.4 Asia Pacific Pneumonia Vaccines Market, by Distribution Channel
1.4.5 Asia Pacific Pneumonia Vaccines Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Pneumonia Vaccines Market by Type
3.1 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 Asia Pacific Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
Chapter 4. Asia Pacific Pneumonia Vaccines Market by Product Type
4.1 Asia Pacific Prevnar 13 Market by Region
4.2 Asia Pacific Synflorix Market by Region
4.3 Asia Pacific Pneumovax 23 Market by Region
Chapter 5. Asia Pacific Pneumonia Vaccines Market by Sector
5.1 Asia Pacific Private sector Market by Region
5.2 Asia Pacific Public sector Market by Region
Chapter 6. Asia Pacific Pneumonia Vaccines Market by Distribution Channel
6.1 Asia Pacific Distribution Partner Companies Market by Region
6.2 Asia Pacific Non-Governmental Organizations (NGO) Market by Region
6.3 Asia Pacific Government Authorities Market by Region
Chapter 7. Asia Pacific Pneumonia Vaccines Market by Region
7.1 China Pneumonia Vaccines Market
7.1.1 China Pneumonia Vaccines Market by Type
7.1.2 China Pneumonia Vaccines Market by Product Type
7.1.3 China Pneumonia Vaccines Market by Sector
7.1.4 China Pneumonia Vaccines Market by Distribution Channel
7.2 Japan Pneumonia Vaccines Market
7.2.1 Japan Pneumonia Vaccines Market by Type
7.2.2 Japan Pneumonia Vaccines Market by Product Type
7.2.3 Japan Pneumonia Vaccines Market by Sector
7.2.4 Japan Pneumonia Vaccines Market by Distribution Channel
7.3 India Pneumonia Vaccines Market
7.3.1 India Pneumonia Vaccines Market by Type
7.3.2 India Pneumonia Vaccines Market by Product Type
7.3.3 India Pneumonia Vaccines Market by Sector
7.3.4 India Pneumonia Vaccines Market by Distribution Channel
7.4 South Korea Pneumonia Vaccines Market
7.4.1 South Korea Pneumonia Vaccines Market by Type
7.4.2 South Korea Pneumonia Vaccines Market by Product Type
7.4.3 South Korea Pneumonia Vaccines Market by Sector
7.4.4 South Korea Pneumonia Vaccines Market by Distribution Channel
7.5 Singapore Pneumonia Vaccines Market
7.5.1 Singapore Pneumonia Vaccines Market by Type
7.5.2 Singapore Pneumonia Vaccines Market by Product Type
7.5.3 Singapore Pneumonia Vaccines Market by Sector
7.5.4 Singapore Pneumonia Vaccines Market by Distribution Channel
7.6 Malaysia Pneumonia Vaccines Market
7.6.1 Malaysia Pneumonia Vaccines Market by Type
7.6.2 Malaysia Pneumonia Vaccines Market by Product Type
7.6.3 Malaysia Pneumonia Vaccines Market by Sector
7.6.4 Malaysia Pneumonia Vaccines Market by Distribution Channel
7.7 Rest of Asia Pacific Pneumonia Vaccines Market
7.7.1 Rest of Asia Pacific Pneumonia Vaccines Market by Type
7.7.2 Rest of Asia Pacific Pneumonia Vaccines Market by Product Type
7.7.3 Rest of Asia Pacific Pneumonia Vaccines Market by Sector
7.7.4 Rest of Asia Pacific Pneumonia Vaccines Market by Distribution Channel
Chapter 8. Company Profiles
8.1 GLAXOSMITHKLINE PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Collaboration, partnerships and agreements:
8.1.1.2 Expansion:
8.1.2 SWOT Analysis
8.2 LG Corporation (LG Chemicals Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Panacea Biotec Limited
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Collaboration, partnerships and agreements:
8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Collaboration, partnerships and agreements:
8.4.5.2 Product launch:
8.4.6 SWOT Analysis
8.5 PnuVax Incorporated
8.5.1 Company Overview
8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
8.6.1 Company Overview
8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
8.7.1 Company Overview
8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
8.8.1 Company overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Walvax Biotechnology Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Product launch:
8.1 Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Collaboration, partnerships and agreements:
8.10.5.2 Product launch:
8.10.6 SWOT Analysis